Merve Yilmaz1, Fatos Dilan Atilla2, Fahri Sahin2, Guray Saydam2. 1. Department of Internal Medicine, Ege University Hospital, 35030, Izmir, Turkey. ornek_merve@hotmail.com. 2. Division of Hematology, Ege University Hospital, Izmir, Turkey.
Abstract
OBJECTIVES: The aim of this study was to assess the association between malnutrition status with the (Global Leadership Initiative on Malnutrition) GLIM criteria and 1-year mortality in hospitalized patients with hematologic malignancy. METHODS: This study included 120 hospitalized patients with hematologic malignancy. Patients who were at risk of malnutrition with NRS2002 were reevaluated with the GLIM criteria for defined malnutrition. Also, the mid-upper arm circumference (MUAC), calf circumference (CC), and handgrip (HG) were measured, and albumin, C reactive protein (CRP), and total protein were recorded to assess malnutrition-related factors. RESULTS: A total of 120 patients are with lymphoma, leukemia, and myeloma having a rate of 34.2%, 34.2%, and 31.6%, respectively, and risk of malnutrition with NRS2002 was established in 82% of patients. Malnutrition with GLIM criteria was seen in 25.8% of patients. The 1-year mortality rate was 41.7% (n = 50). Malnutrition was associated with higher mortality risk independently with age and duration of diagnosis (HR 3.55 (1.99-6.34), p = 0.001). Low HG (HR 0.51 (0.26-0.99), p = 0.03), low albumin (HR 0.39 (0.2-0.6), p = 0.001), and high CRP (HR 2.39 (1.36-4.20), p = 0.002) were significantly associated with increased mortality risk. In contrast, BMI, MUAC, FFMI, and CC were not associated with higher mortality. CONCLUSION: Malnutrition is high with the GLIM criteria. Hospitalized patients with hematologic malignancy with malnutrition have a higher 1-year mortality risk.
OBJECTIVES: The aim of this study was to assess the association between malnutrition status with the (Global Leadership Initiative on Malnutrition) GLIM criteria and 1-year mortality in hospitalized patients with hematologic malignancy. METHODS: This study included 120 hospitalized patients with hematologic malignancy. Patients who were at risk of malnutrition with NRS2002 were reevaluated with the GLIM criteria for defined malnutrition. Also, the mid-upper arm circumference (MUAC), calf circumference (CC), and handgrip (HG) were measured, and albumin, C reactive protein (CRP), and total protein were recorded to assess malnutrition-related factors. RESULTS: A total of 120 patients are with lymphoma, leukemia, and myeloma having a rate of 34.2%, 34.2%, and 31.6%, respectively, and risk of malnutrition with NRS2002 was established in 82% of patients. Malnutrition with GLIM criteria was seen in 25.8% of patients. The 1-year mortality rate was 41.7% (n = 50). Malnutrition was associated with higher mortality risk independently with age and duration of diagnosis (HR 3.55 (1.99-6.34), p = 0.001). Low HG (HR 0.51 (0.26-0.99), p = 0.03), low albumin (HR 0.39 (0.2-0.6), p = 0.001), and high CRP (HR 2.39 (1.36-4.20), p = 0.002) were significantly associated with increased mortality risk. In contrast, BMI, MUAC, FFMI, and CC were not associated with higher mortality. CONCLUSION: Malnutrition is high with the GLIM criteria. Hospitalized patients with hematologic malignancy with malnutrition have a higher 1-year mortality risk.
Authors: E Baltazar Luna; L I Omaña Guzmán; L Ortiz Hernández; S A Ñamendis-Silva; L De Nicola Delfin Journal: Nutr Hosp Date: 2013 Jul-Aug Impact factor: 1.057
Authors: Lisa Martin; Pierre Senesse; Ioannis Gioulbasanis; Sami Antoun; Federico Bozzetti; Chris Deans; Florian Strasser; Lene Thoresen; R Thomas Jagoe; Martin Chasen; Kent Lundholm; Ingvar Bosaeus; Kenneth H Fearon; Vickie E Baracos Journal: J Clin Oncol Date: 2014-11-24 Impact factor: 44.544
Authors: Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni Journal: Age Ageing Date: 2010-04-13 Impact factor: 10.668
Authors: T Cederholm; G L Jensen; M I T D Correia; M C Gonzalez; R Fukushima; T Higashiguchi; G Baptista; R Barazzoni; R Blaauw; A Coats; A Crivelli; D C Evans; L Gramlich; V Fuchs-Tarlovsky; H Keller; L Llido; A Malone; K M Mogensen; J E Morley; M Muscaritoli; I Nyulasi; M Pirlich; V Pisprasert; M A E de van der Schueren; S Siltharm; P Singer; K Tappenden; N Velasco; D Waitzberg; P Yamwong; J Yu; A Van Gossum; C Compher Journal: Clin Nutr Date: 2018-09-03 Impact factor: 7.324
Authors: Carlos A Celis-Morales; Paul Welsh; Donald M Lyall; Lewis Steell; Fanny Petermann; Jana Anderson; Stamatina Iliodromiti; Anne Sillars; Nicholas Graham; Daniel F Mackay; Jill P Pell; Jason M R Gill; Naveed Sattar; Stuart R Gray Journal: BMJ Date: 2018-05-08
Authors: Simone Ummarino; Clinton Hausman; Giulia Gaggi; Lucrezia Rinaldi; Mahmoud A Bassal; Yanzhou Zhang; Andy Joe Seelam; Ikei S Kobayashi; Marta Borchiellini; Alexander K Ebralidze; Barbara Ghinassi; Bon Q Trinh; Susumu S Kobayashi; Annalisa Di Ruscio Journal: Cells Date: 2021-11-02 Impact factor: 7.666
Authors: Palanivel Velmurugan; Vinayagam Moihanavel; Malik A Altayar; Mohammed M Jalal; Saeed M Kabrah; Husam Qanash; Majed N Almashjary; Osama M Alshehri; Vijay Singh Kunwar Journal: Biomed Res Int Date: 2022-07-18 Impact factor: 3.246